Complexes of the platinum(II) tetrachlorodianion with positively charged nuclear dyes have been prepared in an effort to produce neutral molecules which could gain ready access to the nuclear DNA where the platinum(II) tetrachlorodianion could function as a radiosensitizing and a bifunctional alkylating agent. The thiazin dyes Thionin, Azure B, and Methylene Blue, the aminoxanthene dye Pyronin Y, and the thiazole dye Thioflavin have each been complexed to the platinum(II) tetrachlorodianion ( PtCl4) in a ratio of 2:1 ($\text{dye}\colon {\rm PtCl}_{4}$). Studies of the interaction of these complexes and of the dyes with the pBR322 plasmid superhelical DNA demonstrated that while each complex and dye readily associated with the DNA in a dose-dependent manner, only${\rm Pt}(\text{Thioflavin)}_{2}$ and Thioflavin produced irreversible DNA changes (single-strand breaks). In exponentially growing EMT6 cells the cytotoxicity of these drugs was assessed in normally oxygenated and hypoxic cells at both pH 7.4 and 6.45. At concentrations ranging from 1 to 500 μM,${\rm Pt}(\text{Methylene Blue})_{2}$ was significantly more cytotoxic than the other thiazin dye complexes${\rm Pt}(\text{Thionin)}_{2}$ and${\rm Pt}(\text{Azure B)}_{2}$. The cytotoxicity of${\rm Pt}(\text{Thionin)}_{2}$ and${\rm Pt}(\text{Methylene Blue)}_{2}$ was increased in normally oxygenated and hypoxic cells at low pH. Both${\rm Pt}(\text{Pyronin Y)}_{2}$ and${\rm Pt}(\text{Thioflavin)}_{2}$ were more toxic than the thiazin complexes.${\rm Pt}(\text{Pyronin Y)}_{2}$ was most cytotoxic to normally oxygenated cells at normal pH and hypoxic cells at low pH, while${\rm Pt}(\text{Thioflavin)}_{2}$ was most cytotoxic to cells at low pH under both oxygenation conditions. In vitro studies of the radiosensitizing properties of these agents in EMT6 cells demonstrated that exposure to 100 μM for 1 h before and during irradiation (except for${\rm Pt}[\text{Thioflavin]}_{2}$, which was assayed at 25 μM) resulted in enhancement rations of 2.5, 1.9, 1.5 for${\rm Pt}(\text{Azure B)}_{2},{\rm Pt}(\text{Thionin)}_{2},{\rm Pt}(\text{Pyronin Y)}_{2}$, and${\rm Pt}(\text{Thioflavin)}_{2}$, respectively, in hypoxic cells. In contrast,${\rm Pt}(\text{Methylene Blue)}_{2}$ (and Methylene Blue) proved to be a radioprotector of normally oxygenated cells and did not sensitize hypoxic cells to the cytotoxic effects of radiation. In the FSaIIC fibrosarcoma in vivo administration of each drug at 100 mg/kg intraperitoneally (ip) 15 min prior to irradiation (except for${\rm Pt}[\text{Thioflavin]}_{2}$, which was given at 1 mg/kg ip) showed that, with single radiation fractions of 10 and 20 Gy, dose-modifying factors of 2.1, 1.8, 1.5, and 1.2 were produced by${\rm Pt}(\text{Azure B)}_{2},{\rm Pt}(\text{Thionin)}_{2}$, Pt(Pyronin Y), and${\rm Pt}(\text{Methylene Blue)}_{2}$, respectively, after correcting for growth delays induced by the drug alone. In comparison, misonidazole at 1 g/kg ip produced a dose-modifying factor of 1.4. These results indicate that several of these new complexes seem to fulfill expectations in that they appear capable of direct cytotoxicity and radiosensitization.
Skip Nav Destination
Close
Article navigation
February 1990
Research Article|
February 01 1990
Cytotoxicity, Radiosensitization, and DNA Interaction of Platinum Complexes of Thiazin and Xanthene Dyes
Radiat Res (1990) 121 (2): 187–195.
Citation
Beverly A. Teicher, Terence S. Herman, Mark E. Kaufmann; Cytotoxicity, Radiosensitization, and DNA Interaction of Platinum Complexes of Thiazin and Xanthene Dyes. Radiat Res 1 February 1990; 121 (2): 187–195. doi: https://doi.org/10.2307/3577503
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr